TARGET POPULATION: Older adults 65 years of age in all ambulatory and institutional care settings.
The criteria were originally published in the Archives of Internal Medicine in 1991 In 2011, the American Geriatrics Society (AGS) convened an 11-member multidisciplinary panel of experts in geriatric medicine, nursing, and pharmacotherapy to develop the 2012 American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.
Adverse effects of nitrofurantoin include pulmonary toxicity, hepatic dysfunction, peripheral neuropathy, hemolytic anemia, and Clostridium difficile-associated diarrhea.
Previously, nitrofurantoin was on the American Geriatrics Society (AGS) Beers Criteria of medications potentially inappropriate for use in older adults.
The American Geriatric Society has updated the Beers Criteria list based on evidence-based recommendations.
The updated report was published in the Journal of the American Geriatric Society.